Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iradimed (IRMD) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $5.6 million.

  • Iradimed's Consolidated Net Income rose 1043.99% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 million, marking a year-over-year increase of 1907.69%. This contributed to the annual value of $18.5 million for FY2024, which is 1753.58% up from last year.
  • Iradimed's Consolidated Net Income amounted to $5.6 million in Q3 2025, which was up 1043.99% from $5.8 million recorded in Q2 2025.
  • In the past 5 years, Iradimed's Consolidated Net Income ranged from a high of $5.8 million in Q2 2025 and a low of $1.4 million during Q1 2021
  • In the last 5 years, Iradimed's Consolidated Net Income had a median value of $3.9 million in 2021 and averaged $3.8 million.
  • Examining YoY changes over the last 5 years, Iradimed's Consolidated Net Income showed a top increase of 27919.82% in 2021 and a maximum decrease of 2161.2% in 2021.
  • Iradimed's Consolidated Net Income (Quarter) stood at $3.9 million in 2021, then fell by 5.63% to $3.7 million in 2022, then fell by 15.13% to $3.1 million in 2023, then soared by 42.7% to $4.4 million in 2024, then rose by 25.34% to $5.6 million in 2025.
  • Its Consolidated Net Income stands at $5.6 million for Q3 2025, versus $5.8 million for Q2 2025 and $4.7 million for Q1 2025.